DWP
DGX icon

Daymark Wealth Partners’s Quest Diagnostics DGX Stock Holding History

Daymark Wealth Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.23M Sell
19,946
-78
-0.4% -$15.3K 0.1% 153
2026
Q1 		$3.92M Hold
20,024
– – 0.12% 142
2025
Q4 		$3.47M Sell
20,024
-19
-0.1% -$3.46K 0.11% 142
2025
Q3 		$3.82M Sell
20,043
-66
-0.3% -$11.7K 0.13% 136
2025
Q2 		$3.61M Sell
20,109
-444
-2% -$77.1K 0.14% 131
2025
Q1 		$3.48M Sell
20,553
-32
-0.2% -$5.26K 0.15% 117
2024
Q4 		$3.11M Buy
20,585
+631
+3% +$98.1K 0.13% 127
2024
Q3 		$3.1M Sell
19,954
-362
-2% -$54.1K 0.13% 133
2024
Q2 		$2.78M Sell
20,316
-71
-0.3% -$9.72K 0.13% 134
2024
Q1 		$2.71M Sell
20,387
-162
-0.8% -$21K 0.15% 112
2023
Q4 		$2.83M Buy
20,549
+540
+3% +$71K 0.17% 99
2023
Q3 		$2.44M Buy
20,009
+3,373
+20% +$449K 0.17% 108
2023
Q2 		$2.34M Buy
16,636
+14,742
+778% +$2.03M 0.17% 108
2023
Q1 		$268K Buy
+1,894
New +$271K 0.04% 249

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Daymark Wealth Partners's DGX Position: Q2 2026 in Review

Daymark Wealth Partners reduced its Quest Diagnostics (DGX) stake by 0.39% in Q2 2026, selling an estimated $15.3K and leaving 19,946 shares worth $4.23M. The position accounts for 0.1% of the portfolio, ranked #153.

Daymark Wealth Partners first reported a position in DGX in Q1 2023 and has held it in 14 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Daymark Wealth Partners held 19,946 shares of Quest Diagnostics worth $4.23M as of Q2 2026.
  • Daymark Wealth Partners sold 78 Quest Diagnostics shares in Q2 2026, an estimated $15.3K.
  • Quest Diagnostics made up 0.1% of Daymark Wealth Partners's portfolio in Q2 2026, its #153 holding.
  • Daymark Wealth Partners first reported a position in Quest Diagnostics in Q1 2023 and has held it in 14 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.